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Background: The study of insight in bipolar disorder has received limited attention, despite its 
potential impact on treatment compliance and prognosis. In the current study we compare insight 
levels during different phases of bipolar disorder, and consider its relationship to symptoms 
dimensions and epidemiologic variables.
Methods: Insight ratings obtained from 156 bipolar subjects in any phase of bipolar disorder 
were compared. A regression analysis was also conducted to identify symptom dimensions 
predictive of insight levels.
Results: Greater impairments in insight were observed during pure manic episodes than during 
mixed or depressed episodes, or during euthymia. Depressive symptoms were associated with 
better insight. Improvements in insight with treatment were neither complete nor universal. 
Lack of insight was unrelated to age, years of illness, age of first psychiatric illness, or lifetime 
number of hospitalizations.
Conclusions: Although psychosis may be associated with impaired insight, other variables also 
impact on degree of impaired insight. Specifically, depressed mood appears to be associated with 
preservation of insight. That relationship may transcend strict syndromal diagnosis.
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Introduction
The study of insight in mood disorders has traditionally received limited attention, 
despite its possible impact on both treatment compliance and outcome.1–3 Although 
impaired insight has been a focus of study in schizophrenia4–10 and depression,11,12 it 
has been less well studied in bipolar disorder. Studies in bipolar cohorts, however, 
confirm that lack of insight is frequently observed in that disorder as well.13–15
Relationships between poor insight and particular symptoms or symptom clusters 
have also been suggested. One early study suggested a relationship of grandiose-
  euphoria dimension with poor insight in schizophrenia.16 Preserved insight has also been 
observed with depressive symptoms in studies that have focused largely on unipolar 
major depression,11,12 schizophrenia/schizoaffective disorder,4,5,7–10 and mixed mania.13 
Impaired insight and psychotic symptoms are also strongly associated with each other. 
Although this intuitive association is supported by face-validity, it is important to 
observe that the two constructs are neither synonymous, nor inextricably linked.
Although a few studies indicate that the degree of insight impairment may be 
state dependent,17 resolution of the acute affective state or associated psychosis, nei-
ther assures nor stipulates that impairment in insight will fully resolve. Varga et al15 





subsyndromal bipolar I patients, compared with 47% in 
remitted patients. Yen et al14 prospectively observed decreased 
insight during mania compared with euthymia. Insight fol-
lowing either a single manic or depressed episode was similar 
to pre-episode insight but remained at least partially impaired 
in a small group of six subjects who had experienced multiple 
episodes during a two-year period.
In the current study we examine insight in a specifically 
bipolar cohort that is observed in all phases of the illness 
(eg, manic, mixed, depressed, and euthymic). We test for 
state differences in impaired insight, as well as associations 
of impaired insight with particular symptom dimensions 
and course.
Material and methods
Prospectively-obtained ratings and histories of all subjects 
evaluated meeting DSM-IV (Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition) criteria for bipolar 
disorder (manic, mixed, depressed, and euthymic) and had 
been evaluated with the Scale for Manic States (SMS)18 were 
identified in our bipolar database. All subjects had given 
written consent to participate in one or more study of bipolar 
disorder and at the time of evaluation met DSM-IV criteria 
for any phase of bipolar disorder (manic, mixed, depressed, 
and euthymic). In an Institutional Review Board-approved 
process, data were then transferred to a larger database for 
further subsequent analyses. All subjects were in-patients at 
John Umstead Hospital, Butner, North Carolina at the time 
of evaluation. The SMS is a 20-item observer-rated scale for 
bipolar disorder including symptoms drawn from a range of 
symptoms. Factor analyses of scale ratings demonstrated 
that symptoms relate to five independent symptom dimen-
sion: depressed mood, psychomotor pressure, psychosis, 
irritability-paranoia, and hedonic drive.19 The related SMS 
subscales allow for the dimensional assessment of symptoms 
during affective episodes and have been used to supplement 
categorical assessment.20,21 The scale’s reliability and validity 
are reported elsewhere.18 Manic and mixed episode subtypes 
were defined using a definition obtained from receiver operat-
ing characteristic analysis.22 That definition provides a more 
specific and less restrictive alternative to the current DSM-IV 
nomenclature for mixed mania and has been validated using 
epidemiologic variables21,23–25 and biomarkers.26,27
An initial analysis of variance (ANOVA) with post-hoc 
Scheffe-corrected comparisons was conducted to test for dif-
ferences in impaired insight scores (SMS item 13) between 
the diagnostic categories. Impaired insight (SMS item 13) 
represents a composite of denial of illness and rejection of 
treatment. ANOVAs were conducted testing for differences in 
general psychosis (SMS item 10), age, age of first psychiatric 
hospitalization, lifetime number of psychiatric hospitaliza-
tion, and years of illness since first psychiatric hospitalization 
between diagnostic groups. Possible differences in gender and 
race between the groups were also assessed using chi-squared 
statistics. If any of these variables were significant across the 
diagnostic groups, they were included as covariants in the 
final ANOVA comparing insight between the same diagnostic 
groups. ANOVA’s were also conducted testing for gender and 
race interactions with insight in the overall group. Only initial 
ratings of subjects evaluated both during an acute episode and 
following remission were included from the initial between 
group comparisons to avoid violations of independence in 
the analyses. To test for possible relationship between insight 
scores and lifetime severity measures, Pearson correlation 
coefficients were computed between lack of insight score 
(SMS item 13) and other clinical variables (current age, age 
of first psychiatric hospitalization, years since first psychiatric 
hospitalization, and number of lifetime psychiatric hospital-
izations). In a separate analysis to test for state dependence 
of impaired insight between acute episodes and remission, 
insight scores for a subset of subjects evaluated during both 
phases were compared using paired t-tests.
Subscale factor scores were computed by addition of 
relevant items from the SMS to quantify individual symptom 
dimensions for rating during the manic, mixed, depressed, and 
euthymic states, based on a factor analysis in a separate data 
set.19 The constituent symptoms for Factor 1 representing dys-
phoria were depressed mood, anxiety, guilt, suicidality, and 
mood lability. Factor 2, representing psychomotor pressure, 
included motor activity, racing thought, pressured speech, 
and increased interpersonal contact. Factor 3, representing 
psychosis, was calculated as the sum of general psychosis, 
paranoia, and grandiosity. The insight item from the SMS, 
which in previous studies was also included in this factor, was 
excluded to avoid an a priori association. Factor 4, reflecting 
hedonic drive, included grandiosity, euphoria, humor, and 
hypersexuality. Factor 5 comprised paranoia, irritability, and 
aggression. A logistic regression was conducted with insight 
score as the dependent variable, and each of the factor scores 
as independent variables.
Results
Ratings of 156 subjects were obtained. Eighty-six were evalu-
ated during pure manic episodes, 29 during mixed manic 
episodes, 14 during bipolar depressed episodes, and 27 in 
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Ninety-five were white and 61 were black. Their mean age 
was 41.5 years (standard deviation [SD] 11.8, range 18–70). 
Subjects had an average of 7.7 (SD 8.4) lifetime psychiatric 
hospitalizations, had been ill 14.8 (SD 12.4) years since their 
first hospitalization, and had a mean age at first psychiatric 
hospitalization of 28.8 (SD 11.0) years.
Differences between lack of insight scores were noted 
between diagnostic groups (F = 16.8, P , 0.001). The mean 
lack of insight score of the pure manic group (2.395, SD 
1.625) was significantly greater than the mean of the mixed 
manic group (1.345, SD 1.495, P = 0.012), bipolar depressed 
group (0.571, SD 0.852, P , 0.001), and the euthymic group 
(0.444, SD 0.934, P , 0.001). No group differences were 
observed between the mixed manic, bipolar depressed, or 
bipolar euthymic groups.
Differences in general psychosis scores were also 
observed across the diagnostic groups in a separate ANOVA 
(F = 23.179, P , 0.001). Both the pure manic group (2.86, SD 
1.595) and mixed manic group (2.276, SD 1.771) had greater 
mean psychosis scores than the euthymic group (0.185, SD 
0.483), but did not differ from each other. In addition the gen-
eral psychosis scores in the pure manic group (2.86, SD 1.595) 
were greater than in the bipolar depressed group (1.429, SD 
1.505, P = 0.013). Other group comparisons of psychosis were 
not significant (ns). No between group differences were noted 
for age (F = 1.136, ns), number of lifetime psychiatric hospi-
talizations (F = 0.068, ns), age of first psychiatric hospitaliza-
tion (F = 0.264, ns), or length of illness since first psychiatric 
hospitalization (F = 0.238, ns). Impaired insight scores were 
lower in whites (1.305, SD 1.530) than African Americans 
(2.311, SD 1.669, F = 14.958, P , 0.001), and a trend was 
also noted for lower scores in females (1.443, SD 1.529) 
than males (1.907, SD 1.733, F = 3.073, P = 0.08). Using 
chi-squared statistics, overall differences were also noted for 
race (χ2 = 20.2, degrees of freedom [df] = 3, P , 0.001) and 
gender (χ2 = 9.3, df = 3, P , 0.05) between the diagnostic 
groups. When the ANOVA was conducted comparing lack 
of insight across the four diagnostic groups, including general 
psychosis, gender, and race as a covariates, overall differences 
in lack of insight were maintained (F = 4.007, P = 0.009). 
Psychosis scores remained relevant to the lack of insight score 
(F = 21.1, P , 0.001), however gender (F = 0.112) and race 
(F = 3.293) effects were not observed.
Lack of insight was not significantly correlated with 
current age (r = 0.069), lifetime number of psychiatric hos-
pitalization (r = -0.044), age of first psychiatric hospitaliza-
tions (r = 0.013), or years of illness since first psychiatric 
hospitalization (r = 0.054).
The regression for the prediction of lack of insight from 
manic rating factor scores was significant (F = 31.123, 
P , 0.001, R-squared = 0.509). Four factors were significant 
in the regression model for the prediction of lack of insight. 
Psychosis, psychomotor pressure, and irritable-aggression 
scores were positively related to impaired insight (Table 1), 
while higher levels of depressive symptoms were predictive 
of better insight. The remaining factor, hedonic drive, was 
not significant.
Seventeen subjects evaluated in mixed (10) or pure (7) 
manic episodes were reevaluated following remission. Mean 
lack of insight scores were higher (2.176, SD 1.912) during 
the acute episodes than during remission (0.412, SD 0.795, 
t = 3.85, df = 16, P , 0.001). Four of the 12 subjects who 
had lack of insight scores of one or greater during mixed or 
pure episodes, defined as moderate or greater impairment, 
continued to have scores in that range following remission.
Discussion
Impaired insight is frequently observed in patients with bipolar 
disorder, particularly during pure manic episodes. Fully 73 of 
86 (84.9%) subjects during pure mania had insight scores of 
one or greater, indicating at least a moderate denial of illness. 
Although less common during other episodes, moderate denial 
of illness was nonetheless noted in 17 of 29 (58.6%) of subjects 
during mixed manic episodes, five of 14 (35.7%) during bipolar 
depressed episodes and six of 27 (22.2%) during euthymia.
In our initial analyses possible racial and gender dif-
ferences in insight scores were noted. When insight scores 
across diagnostic groups were compared, including these two 
covariates, however, neither remained significant. Hence, 
gender and racial differences may be explained by differ-
ences in distribution of the different diagnostic groups. In 
previous studies we have observed an association of mixed 
manic episodes with both female gender and white race25 
compared with pure manic episodes.
Received wisdom usually associates lack of insight 
with increased psychosis, which is an intuitive connection. 
Table  1  regression  analysis  of  symptom  dimension  for  the 
prediction of impaired insight
Variable β P 95% confidence  
interval
Dysphoria -0.130 0.034 -0.106 – -0.004
Psychomotor agitation 0.208 0.029 0.007–0.129
Psychosis 0.247 0.006 0.029–0.170
hedonic drive -0.124 0.176 -0.117–0.022





Most relevant studies have confirmed that observation 
in   schizophrenia/schizoaffective disorder4–7 and mixed 
diagnostic cohorts.11 Our data confirms that association 
as well in an exclusively bipolar cohort. Impaired insight, 
however, is not predicated on psychosis alone. Whether 
viewed syndromally or dimensionally, depression appears 
to be relevant to the preservation of insight during acute 
episodes. Ratings of insight during bipolar depression and 
mixed states, both states characterized by depressive features, 
showed less impairment in insight than ratings during pure 
manic states, even with the inclusion of statistical adjustments 
for differing degrees of concurrent psychosis. Moreover, 
depressive symptoms, independent of episode diagnosis, 
were a negative predictor of impaired insight across the entire 
cohort. These findings are in consonance with studies that 
have focused largely on unipolar major depression11,12 and 
schizophrenia/schizoaffective disorder,4,5,7–10 and a previous 
earlier independent study that compared only mixed and 
pure manic states exclusively.13 Viewed collectively, the 
relationship of depression to insight appears to transcend 
strict syndromal diagnosis.
Previous researchers have also suggested that a grandiose-
euphoria dimension might be related with poor insight in 
schizophrenia,16 although never clearly substantiated. Our 
study, too, does not suggest a relationship. Hedonic drive, 
including euphoria and grandiosity, as well as hypersexual-
ity and humor, was not predictive of poor insight. Hence, 
it appears that it is the degree of dysphoria, rather than 
euphoria, that is essential to level of insight observed during 
acute bipolar episodes.
Psychomotor agitation and irritability were also predic-
tive of lack of insight during acute episodes. Both represent 
core features of mania and may reflect overall severity during 
manic episodes. Impaired insight in a hospitalized cohort 
might also tend to foster irritability, or at least its manifesta-
tion. Correlations between longitudinal severity markers (eg, 
length of illness since first hospitalization, age of first hospi-
talization, number of lifetime psychiatric hospitalizations), 
however, were not significant in these analyses. Hence, in this 
small naturalistic study, it did not appear that insight either 
improved with length of illness or number of hospitaliza-
tions, or worsened with a prolonged or deteriorating course. 
Whether these two factors in some way may counterbalance 
the effect of each other is unclear.
Impaired insight is sometimes naively regarded as a 
secondary measure emanating from psychotic symptoma-
tology and tracking with global illness severity. Under that 
paradigm, insight would improve as primary symptoms 
improve. Although improvement in insight was observed 
with treatment, that improvement was neither universal nor 
complete, again highlighting the dissociation of constructs.
Some limitations to the study should be noted. The cohort 
comprised exclusively hospitalized subjects and recruitment 
bias may have impacted the study given the potential for 
subjects with less insight to be less willing to participate in 
research studies. Our measure of insight was extracted from 
a scale item focusing on global insight and acceptance of 
treatment.
Nonetheless, the importance of insight in bipolar disorder 
is obvious. It is relevant both during acute bipolar episodes 
and during remission. It may impact on acceptance of 
treatments during acute phases of the illness, as well as on 
compliance with prophylactic treatment and recognition of 
early warning signs of relapse.
Conclusion
Impaired insight is common in bipolar disorder and may 
impact on compliance and treatment outcome. Although 
insight may, to some degree, be state-dependent, impairments 
can persist following resolution of other symptomatology. 
Psychosis, although distinct from impaired insight, is posi-
tively associated with it, while depression has a negative asso-
ciation. Psychomotor acceleration and irritability, both core 
features of mania, were also associated with poor insight.
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